
Cayuga Biotech
Cayuga Biotech is developing novel therapies to address life-threatening hemorrhage by harnessing the body’s innate ability to stop bleeding.
About Cayuga Biotech
Recent Funding lists Cayuga Biotech under Health and bio (also Cybersecurity). It went through IndieBio (IndieBio NY 01). It was founded by Damien Kudela and Kyle Ploense.
Funding rounds
- IndieBio NY 01
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
- DKDamien Kudela Founder, Chief Science Officersource: cayugabiotech.com
KP
Kyle Ploense Co-foundersource: cayugabiotech.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Cayuga Biotech: questions and answers
- Who invested in Cayuga Biotech?
- Investors on record for Cayuga Biotech: IndieBio.
- Who founded Cayuga Biotech?
- Cayuga Biotech was founded by Damien Kudela (Founder, Chief Science Officer) and Kyle Ploense.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cayuga-biotech (get a free API key).